Non Serious Adverse Drug Reactions Report

Start Date:2016-05-16 End Date:2016-05-17
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0043Subject Initials :F-HDOB :03/13/1983Sex:FemaleRace:AsianHeight:164cmWeight:54.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/13/2015225
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/30/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparoscopic tubal ectopic pregnancy at the right side of the window to take embryoUk-Unk-2005Not on treatment/medication
Under the right fallopian tube ectopic pregnancy laparoscopic surgeryUk-Unk-2007Not on treatment/medication



17-MAY-16
NA/EMR700623-541/C02-0043
Page 1 of15
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-16 End Date:2016-05-17
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0046Subject Initials :Q-HDOB :10/07/1985Sex:FemaleRace:AsianHeight:161cmWeight:50.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/13/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/28/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



16-MAY-16
NA/EMR700623-541/C02-0046
Page 2 of15
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-16 End Date:2016-05-17
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0049Subject Initials :HPTDOB :09/16/1980Sex:FemaleRace:AsianHeight:155cmWeight:50.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015187.5
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/31/201506/03/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparoscopic surgery appendicitisUk-Unk-2012Not on treatment/medication



16-MAY-16
NA/EMR700623-541/C02-0049
Page 3 of15
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-16 End Date:2016-05-17
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0052Subject Initials :YLLDOB :02/07/1992Sex:FemaleRace:AsianHeight:165cmWeight:54.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/30/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



16-MAY-16
NA/EMR700623-541/C02-0052
Page 4 of15
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-16 End Date:2016-05-17
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0138Subject Initials :TTJDOB :06/20/1990Sex:FemaleRace:AsianHeight:150cmWeight:41.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/22/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/06/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Ectopic pregnancy laparoscopic surgery: the right fallopian tube embryo pelvic sticking pointsUk-Jan-2014Not on treatment/medication
Hysteroscopy: endometrial polyps.Uk-Feb-2015Not on treatment/medication



16-MAY-16
NA/EMR700623-541/C02-0138
Page 5 of15
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-16 End Date:2016-05-17
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0161Subject Initials :H-YDOB :12/12/1985Sex:FemaleRace:AsianHeight:166cmWeight:57.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/26/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/10/201506/16/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal obstruction Uk-Unk-2007Not on treatment/medication
Laparoscopic tubal surgery sticking points. Uk-Unk-2007Not on treatment/medication
Open left fallopian tube ectopic pregnancy surgeryUk-Unk-2012Not on treatment/medication



16-MAY-16
NA/EMR700623-541/C02-0161
Page 6 of15
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-16 End Date:2016-05-17
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0178Subject Initials :XSCDOB :10/11/1988Sex:FemaleRace:AsianHeight:155cmWeight:54.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/27/2015200
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/10/201506/16/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal resistance. Uk-Jan-2013Not on treatment/medication
Laparoscopy surgery: pelvic adhesions dissection, bilateral salpingo-repair plastic surgery, normal uterine shape.Uk-Jan-2013Not on treatment/medication
Hysteroscopy normal, water surgery: incomplete right fallopian tube obstructionUk-Feb-2015Not on treatment/medication



17-MAY-16
NA/EMR700623-541/C02-0178
Page 7 of15
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-16 End Date:2016-05-17
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0179Subject Initials :HYZDOB :05/14/1991Sex:FemaleRace:AsianHeight:158cmWeight:53.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/27/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/11/201506/16/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Ectopic pregnancy laparotomy: the left fallopian tube removal.Uk-Unk-2009Not on treatment/medication
Abdominal ectopic pregnancy conservative surgery.Uk-Unk-2010Not on treatment/medication
Hysteroscopy: endometrial polyp excision.Uk-Jan-2015Not on treatment/medication



17-MAY-16
NA/EMR700623-541/C02-0179
Page 8 of15
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-16 End Date:2016-05-17
Study :EMR200136_583Investigator :NACountry of Investigator :RomaniaSiteNo:007
Subject No :007-0003Subject Initials :DOB :04/19/1977Sex:FemaleRace:CaucasianHeight:173(cm)Weight:60(kg)
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Visit 2 (Month 3)05/04/20159
Visit 5 (Month12)/Early Termination
Visit 3 (Month 6)05/04/20159
Visit 1/ Baseline (Day 1)05/04/20159
Visit 4 (Month 9)05/04/20159
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
elevated ALT and AST05/30/201510/31/2015SuspectedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
Concomitant medication(Othervalue:)Not applicableConcomitant medicationResolved
Event description:
Subject received concomitant medications:Yes
Name of medicationStart DateOngoingEnd DateDoseUnitFrequency
Paracetamol05/04/201507/17/2015500mgPRN
LIV 5205/30/201507/19/20153tbTID
LIV 5207/20/2015Yes12/12/20156tbTID
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



17-MAY-16
NA/EMR200136_583/007-0003
Page 9 of 15